Geode Capital Management, LLC Acorda Therapeutics Inc Transaction History

Geode Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.55 - $1.0 $536 - $976	-976 Reduced 1.44%	66,693 $39,000
Q4 2022 Feb 13, 2023	BUY	$0.52 - $0.77 $10,892 - $16,129	20,948 Added 44.84%	67,669 $51,000
Q3 2021 Nov 12, 2021	SELL	$3.36 - $4.79 $90,185 - $128,568	-26,841 Reduced 36.49%	46,721 $214,000
Q2 2021 Aug 13, 2021	BUY	$3.61 - $5.23 $31,428 - $45,532	8,706 Added 13.42%	73,562 $350,000
Q1 2021 May 12, 2021	SELL	$3.8 - $8.04 $1.27 Million - $2.69 Million	-334,393 Reduced 83.76%	64,856 $315,000
Q4 2020 Feb 12, 2021	BUY	$3.12 - $6.6 $1.25 Million - $2.64 Million	399,249 New	399,249 $283,000

133K

Ticker ACOR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 24,338,400
Market Cap $6.33M
Description
Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); and Inbrija for the treatment of OFF periods in Parkinson's disease in Europe. It also...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.